<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03737175</url>
  </required_header>
  <id_info>
    <org_study_id>china carotid</org_study_id>
    <nct_id>NCT03737175</nct_id>
  </id_info>
  <brief_title>Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients</brief_title>
  <acronym>ESCALATE</acronym>
  <official_title>Endarterectomy vs Stenting in Chinese Asymptomatic Carotid Stenosis Patients: Prospective, Multiple Center, Randomized Controlled Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Changzheng Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endarterectomy vs Stenting Asymptomatic Carotid stenosis patients to verify the efficacy and&#xD;
      safety.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endarterectomy vs Stenting Asymptomatic Carotid stenosis patients to verify the efficacy and&#xD;
      safety.Study Design is a prospective, multiple center, randomized controlled trail.600 cases&#xD;
      enrollment predict，each group including carotid artery stenting and carotid endarterectomy&#xD;
      300 cases.Follow-up period of 2 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 30, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of composite endpoints of myocardial infarction, stroke, and any death</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of composite endpoints of myocardial infarction, stroke, and any death at 30 days follow up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgery success rate</measure>
    <time_frame>1 day</time_frame>
    <description>Surgery success rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of complications within 30 days, complications include：Cranial nerve and peripheral nerve injury, vascular injury, non cerebral hemorrhage, wound complications as neck incision or related to puncture site, and other (such as anesthesia) complications；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of myocardial infarction</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of myocardial infarction at 30 days follow up;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Ipsilateral stroke</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of Ipsilateral stroke at 30 days follow up;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Bilateral stroke</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of Bilateral stroke at 30 days follow up；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ipsilateral stroke</measure>
    <time_frame>12 months</time_frame>
    <description>Incidence of ipsilateral stroke at 12 months follow up；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carotid restenosis rate</measure>
    <time_frame>12、24 months</time_frame>
    <description>Carotid restenosis rate at 12、24 months follow up；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of target lesion revascularization</measure>
    <time_frame>6、12、24 months</time_frame>
    <description>Incidence of target lesion revascularization at 6、12、24 months follow up；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of composite endpoints of myocardial infarction, stroke, and any death</measure>
    <time_frame>6、12、24 months</time_frame>
    <description>Incidence of composite endpoints of myocardial infarction, stroke, and any death at 6、12、24 months follow up；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major stroke and minor stroke</measure>
    <time_frame>6、12、24 months</time_frame>
    <description>Incidence of major stroke and minor stroke at 6、12、24 months follow up；</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical time</measure>
    <time_frame>Through hospital stay，an average of 10days</time_frame>
    <description>Surgical time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization days</measure>
    <time_frame>Through hospital stay，an average of 10days</time_frame>
    <description>Hospitalization days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization fees</measure>
    <time_frame>Through hospital stay，an average of 10days</time_frame>
    <description>Hospitalization fees</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Carotid Artery Stenting group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carotid Artery Stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carotid Endarterectomy group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Carotid Endarterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid Artery Stenting</intervention_name>
    <description>Carotid Artery Stenting</description>
    <arm_group_label>Carotid Artery Stenting group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid Endarterectomy</intervention_name>
    <description>Carotid Endarterectomy</description>
    <arm_group_label>Carotid Endarterectomy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Clinical Criteria&#xD;
&#xD;
          1. Age≥50 years，sex unlimited；&#xD;
&#xD;
          2. Asymptomatic carotid stenosis ，ie no transient ischemic attack、stroke or other related&#xD;
             neurological symptom caused by carotid stenosis in the past 6 months.(Only the&#xD;
             clinical manifestations of dizziness or mild headache are considered asymptomatic&#xD;
             carotid stenosis.)；&#xD;
&#xD;
          3. The patient understands the trial objective，understands and accepts the duration of&#xD;
             the study，is able and willing to comply with all requirements，including follow-up and&#xD;
             evaluation of it, voluntarily participates in the study and signs Informed Consent&#xD;
             Form.&#xD;
&#xD;
             Anatomy Criteria&#xD;
&#xD;
          4. Internal carotid artery independent disease.（ Involving or not involving adjacent&#xD;
             common carotid arteries is permitted.）；&#xD;
&#xD;
          5. Carotid stenosis satisfies one of the following criteria ：&#xD;
&#xD;
               1. Ultrasonography suggests stenosis ≥ 70%，or angiography showed stenosis ≥ 60%；&#xD;
&#xD;
               2. Ultrasonography suggests stenosis &lt; 70%，but angiography or other examination&#xD;
                  showed stenosis in an unstable state；&#xD;
&#xD;
          6. Patients with bilateral carotid stenosis, the treatment time for target vessel&#xD;
             contralateral vessels is required 30 days before enrollment or 30 days after&#xD;
             completion of study procedure；&#xD;
&#xD;
          7. The stent can reach the site of lesion smoothly as expected.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical Criteria&#xD;
&#xD;
               1. Patients with progressive stroke in the past 3 months or recent (Within 7 days)，&#xD;
                  CT or MRI suggested that the lesion is large，and may be with the risk of&#xD;
                  hemorrhagic transformation；&#xD;
&#xD;
               2. Patients with anesthesia contraindications；&#xD;
&#xD;
               3. Serious ipsilateral stroke occurred in the past and may confuse the judgment of&#xD;
                  the study endpoint；&#xD;
&#xD;
               4. Patients with severe dementia；&#xD;
&#xD;
               5. Patients with spontaneous intracerebral hemorrhage in the past 12 months；&#xD;
&#xD;
               6. Large size of cerebral infarction or myocardial infarction occurred within 30&#xD;
                  days ；&#xD;
&#xD;
               7. Patients with large intracranial aneurysms (diameter&gt; 5mm)，and cannot be treated&#xD;
                  in advance or contemporaneous；&#xD;
&#xD;
               8. Chronic total occlusion without obvious cerebral ischemia symptoms；&#xD;
&#xD;
               9. Hemoglobin &lt;100 g/l， Platelet count &lt;125×109/L， INR&gt;1.5， Bleeding time &gt; 1&#xD;
                  min，patients with exceeding the upper limits of normal，or heparin-related&#xD;
                  thrombocytopenia；&#xD;
&#xD;
              10. Patients unable to perform normal angiographic evaluation or unsafe percutaneous&#xD;
                  puncture point；&#xD;
&#xD;
              11. Patients with neurologic disorder that caused transient or permanent neurological&#xD;
                  deficits within 2 years before the surgery and can not be identified with&#xD;
                  transient ischemic attack or stroke；&#xD;
&#xD;
              12. Patients with other cardiac emboli sources, such as left ventricular aneurysm,&#xD;
                  intraluminal filling defect, cardiomyopathy, aortic or mitral prosthetic heart&#xD;
                  valve, calcific aortic stenosis, infective endocarditis, mitral stenosis, atrial&#xD;
                  septal defect, atrial septal aneurysm, or left atrial myxoma；&#xD;
&#xD;
              13. Recent gastrointestinal bleeding and affects antiplatelet therapy；&#xD;
&#xD;
              14. Surgical contraindications or patients with high risk of surgery defined as&#xD;
                  having any of the following： It is known that two or more proximal or main&#xD;
                  coronary artery stenosis ≥70%, untreated or unable to pass； Ejection fraction&#xD;
                  &lt;30% or New York Heart Association (NYHA) functional class III or higher；&#xD;
                  Unstable angina，ie angina at resting state and electrocardiogram changes；&#xD;
                  Currently waiting main organ transplants (ie heart, lung, liver, kidney), or are&#xD;
                  doing relevant evaluate； Malignant tumor or respiratory insufficiency, life&#xD;
                  expectancy &lt; 5 years or forced expiratory volume at one second &lt; 30% (predicted)；&#xD;
                  Dialysis-dependent renal failure； Poor control of diabetes, fasting blood glucose&#xD;
                  &gt;22mmol/L and ketone body &gt; +2； Need to perform other general anesthesia during&#xD;
                  the same period；&#xD;
&#xD;
              15. There may be one or more anatomical conditions affecting the normal operative&#xD;
                  approach in patients with contraindications for carotid endarterectomy operation；&#xD;
                  there may be one or more anatomic situations to increase the risk of adverse&#xD;
                  events in patients with high operative risk；including： Neck radiation therapy&#xD;
                  history； Radical neck surgery history； Inoperable lesions (ie more than C2&#xD;
                  lesions)； Spinal brake - unable to bend neck, or kyphotic deformity； Symptomatic&#xD;
                  dissection of the carotid siphon below； Common carotid artery opening&#xD;
                  lesion；present tracheotomy； Contralateral recurrent laryngeal nerve paralysis；&#xD;
                  Previously performed ipsilateral carotid endarterectomy，intracranial or&#xD;
                  subclavian arterial bypass surgery； Contralateral carotid artery occlusion；&#xD;
                  Lesions series； Severe long segment calcification of the carotid artery；&#xD;
                  Inaccessible lesions by endoluminal methods (Severe distortion of the aortic arch&#xD;
                  branch, no suitable introduction of arteries, aortic arch anatomy special）；&#xD;
&#xD;
              16. Investigators consider the patient inappropriate to participate in this clinical&#xD;
                  trial；&#xD;
&#xD;
              17. Those who participated in clinical trials of other drugs or medical devices&#xD;
                  before the inclusion did not reach the end of the time limit.&#xD;
&#xD;
                  Angiography criteria&#xD;
&#xD;
              18. Severe vascular tortuosity, or anatomical conditions may affect the safe&#xD;
                  locomotion of guide catheter, guide sheath or stent；&#xD;
&#xD;
              19. Patients with ipsilateral carotid artery stenting or having a graft；&#xD;
&#xD;
              20. Patients with severe or extensive arteriosclerosis, involving the aortic arch and&#xD;
                  the proximal common carotid artery, causing locomotion danger of guide catheter&#xD;
                  or guide sheath；&#xD;
&#xD;
              21. Carotid endarterectomy contraindications by angiography：severity of intracranial&#xD;
                  or extracranial arterial stenosis that exceeds target lesions; cerebrovascular&#xD;
                  arteriovenous malformations; or other contraindications;&#xD;
&#xD;
              22. Patients with contralateral carotid artery stenosis, are expected to be performed&#xD;
                  within 30 days of the perioperative period of the study；&#xD;
&#xD;
              23. Occlusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YongQuan Gu YQ Gu, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>YongQuan Gu YQ Gu, Prof.</last_name>
    <phone>+8615901598209</phone>
    <email>guyongquan@xwhosp.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>JianMing Guo JM Guo</last_name>
    <phone>+8613146369562</phone>
    <email>guojianming@aliyun.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sino-Japanese Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peng Liu P Liu, Prof.</last_name>
      <phone>+8613701333388</phone>
    </contact>
    <contact_backup>
      <last_name>ZhiDong Ye ZD Ye</last_name>
      <phone>+8613910682488</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shanghai Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ZhiQing Zhao ZQ Zhao, Prof.</last_name>
      <phone>+8613301617866</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai ChangZheng Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LeFeng Qu LF Qu, Prof.</last_name>
      <phone>+8618616505267</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital affiliated to Fudan University</name>
      <address>
        <city>Shanghai</city>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DaQiao Guo DQ Guo, Prof.</last_name>
      <phone>+8613801785258</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated Hospital of Xi ' an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <zip>710000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JianLin Liu JL Liu, Prof.</last_name>
      <phone>+8613709250539</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhen Li Z Li, Prof.</last_name>
      <phone>+8618303710000</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007 Dec;6(12):1063-72. Epub 2007 Nov 13. Review.</citation>
    <PMID>17993293</PMID>
  </reference>
  <reference>
    <citation>North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, Ferguson GG, Fox AJ, Rankin RN, Hachinski VC, Wiebers DO, Eliasziw M. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 Aug 15;325(7):445-53.</citation>
    <PMID>1852179</PMID>
  </reference>
  <reference>
    <citation>MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet. 1991 May 25;337(8752):1235-43.</citation>
    <PMID>1674060</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>November 8, 2018</last_update_submitted>
  <last_update_submitted_qc>November 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xuanwu Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>Yong-Quan Gu</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

